Merial, a world-leading animal health company, has gained full-licensure from the U.S. Department of Agriculture for ONCEPT Canine Melanoma Vaccine, DNA. ONCEPT is a breakthrough vaccine indicated for aiding in extending survival of dogs with stage II or stage III oral canine melanoma, a common yet deadly form of cancer in dogs.
- Canine Cancer Breakthrough: Could This Be First Effective Cancer Vaccination?
- World’s First Vaccine Against Canine Flu is Announced
- Major Canine Cancer Breakthrough
Enter your email address below and never miss out on the latest, most important dog news: